FDA approves Telix Pharmaceuticals’ prostate cancer treatment

Sydney, Australia (CU)_ Illuccix, a prostate cancer imaging tool developed by Telix Pharmaceuticals (TLX), has been authorized by the US Food and Drug Administration. The product is a kit for making an…